Log In
Print
BCIQ
Print
Print this Print this
 

CDX-1401

  Manage Alerts
Collapse Summary General Information
Company Celldex Therapeutics Inc.
DescriptionFusion protein consisting of a human mAb with specificity for the dendritic cell receptor linked to NY-ESO-1
Molecular Target Cancer/testis antigen 1B (CTAG1B) (NY-ESO-1)
Mechanism of ActionVaccine
Therapeutic ModalityBiologic: Fusion protein
Latest Stage of DevelopmentPhase I/II
Standard IndicationSolid tumors
Indication DetailsTreat advanced cancers expressing NY-ESO-1; Treat multiple solid tumors
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today